Search

Andrew D. Stclair

Examiner (ID: 13672)

Most Active Art Unit
3799
Art Unit(s)
3743, 4175, PFMU, 3749, OPLA, 3754, 3753, 3799
Total Applications
400
Issued Applications
218
Pending Applications
1
Abandoned Applications
179

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 8227268 [patent_doc_number] => 20120141478 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'COMPOSITIONS AND METHODS FOR DELIVERING ANTI-ACTIVATED RAS ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/304278 [patent_app_country] => US [patent_app_date] => 2007-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 15054 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12304278 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/304278
COMPOSITIONS AND METHODS FOR DELIVERING ANTI-ACTIVATED RAS ANTIBODIES Jun 7, 2007 Abandoned
Array ( [id] => 6582696 [patent_doc_number] => 20100129933 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'METHOD FOR DETECTING THE BINDING BETWEEN MDM2 AND THE PROTEASOME' [patent_app_type] => utility [patent_app_number] => 12/597356 [patent_app_country] => US [patent_app_date] => 2007-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15248 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20100129933.pdf [firstpage_image] =>[orig_patent_app_number] => 12597356 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/597356
METHOD FOR DETECTING THE BINDING BETWEEN MDM2 AND THE PROTEASOME Apr 25, 2007 Abandoned
Array ( [id] => 5165281 [patent_doc_number] => 20070286865 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-13 [patent_title] => 'Use of HE4 and other biochemical markers for assessment of ovarian cancers' [patent_app_type] => utility [patent_app_number] => 11/650337 [patent_app_country] => US [patent_app_date] => 2007-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11378 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20070286865.pdf [firstpage_image] =>[orig_patent_app_number] => 11650337 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/650337
Use of HE4 and other biochemical markers for assessment of ovarian cancers Jan 3, 2007 Abandoned
Array ( [id] => 4909707 [patent_doc_number] => 20080020473 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-24 [patent_title] => 'Use of HE4 and other biochemical markers for assessment of endometrial and uterine cancers' [patent_app_type] => utility [patent_app_number] => 11/650573 [patent_app_country] => US [patent_app_date] => 2007-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10462 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20080020473.pdf [firstpage_image] =>[orig_patent_app_number] => 11650573 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/650573
Use of HE4 and other biochemical markers for assessment of endometrial and uterine cancers Jan 3, 2007 Abandoned
Array ( [id] => 5385176 [patent_doc_number] => 20090226421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'RECOMBINANT MONOVALENT ANTIBODIES AND METHODS FOR PRODUCTION THEREOF' [patent_app_type] => utility [patent_app_number] => 12/095023 [patent_app_country] => US [patent_app_date] => 2006-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 57225 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20090226421.pdf [firstpage_image] =>[orig_patent_app_number] => 12095023 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/095023
Recombinant monovalent antibodies and methods for production thereof Nov 27, 2006 Issued
Array ( [id] => 7422456 [patent_doc_number] => 20040229300 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Zinc-based screening test and kit for early diagnosis of prostate cancer' [patent_app_type] => new [patent_app_number] => 10/829732 [patent_app_country] => US [patent_app_date] => 2004-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9074 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20040229300.pdf [firstpage_image] =>[orig_patent_app_number] => 10829732 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/829732
Zinc-based screening test and kit for early diagnosis of prostate cancer Apr 21, 2004 Abandoned
Array ( [id] => 5539704 [patent_doc_number] => 20090221509 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'Tumour-associated peptides binding to MHC-molecules' [patent_app_type] => utility [patent_app_number] => 10/549718 [patent_app_country] => US [patent_app_date] => 2004-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7799 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20090221509.pdf [firstpage_image] =>[orig_patent_app_number] => 10549718 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/549718
Tumour-associated peptides binding to MHC-molecules Mar 22, 2004 Abandoned
Array ( [id] => 5655222 [patent_doc_number] => 20060140957 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Eph/ephrin mediated modulation of cell adhesion and tumour cell metastasis' [patent_app_type] => utility [patent_app_number] => 10/544701 [patent_app_country] => US [patent_app_date] => 2004-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13594 [patent_no_of_claims] => 78 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0140/20060140957.pdf [firstpage_image] =>[orig_patent_app_number] => 10544701 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/544701
Eph/ephrin mediated modulation of cell adhesion and tumour cell metastasis Feb 8, 2004 Abandoned
13/138698 HIGH AFFINITY T-CELL RECEPTOR-LIKE NY-ESO-1 PEPTIDE ANTIBODIES, METHODS AND USES THEREOF - Abandoned
Menu